Please wait ...

Stefan Gravenstein, MD, MPH


Dr. Stefan Gravenstein is a geriatrician that has served as director or chief of geriatrics in three academic institutions, now the Director, Division of Geriatrics and Palliative Medicine at the Alpert Medical School of Brown University. Dr. Gravenstein has a long-standing interest in immunity, inflammation, cardiovascular outcomes and aging especially in the context of infection, vaccines and the long-term care setting, and the topic of the majority of his publications.

Dr. Gravenstein discloses the following:
He has received research support from: Seqirus, Sanofi, Pfizer
He is on the Advisory Board for Novavax, Sanofi, Pfizer, VaxArt, Janssen
He is on the speakers’ Bureau for Seqirus, GSK
He is on the Data and Safety Monitoring Board for Longevoron, SciClone

Product Type
Conference

On Demand: AOMA 100th Annual Convention Encore CME Bundle


Total Credits: 34.5 including 34.5 AOA Category 1-A, 34.5 AMA PRA Category 1

Average Rating:
Not yet rated
Short Description:
You asked and we responded! Although we would love to see and connect with you in person, we realize that may not be feasible (or preferable) for all. So, in addition to the AOMA 100th Annual Conventi...
Price:
$1,285.00 - Non-Member Physician

Product Type
Conference

On Demand: AOMA 100th Annual Convention Greatest Hits CME Bundle


Total Credits: 20.0 including 20.0 AOA Category 1-A, 20.0 AMA PRA Category 1

Average Rating:
Not yet rated
Short Description:
You asked and we responded! Although we would love to see and connect with you in person, we realize that may not be feasible (or preferable) for all. So, in addition to the AOMA 100th Annual Conventi...
Price:
$885.00 - Non-Member Physician Registration

Product Type
On Demand

Respiratory Syncytial Virus (RSV): Recognizing and Mitigating Risk in Vulnerable Adults


Total Credits: 1.0 including 1.0 AOA Category 1-A, 1.0 AMA PRA Category 1

Average Rating:
Not yet rated
Duration:
0:55
Format:
Audio and Video
Short Description:
Like with influenza, RSV and other respiratory virus activity and associated hospitalizations declines with the “lockdown” response to the SARS-CoV-2 pandemic
Price:
$40.00 - Non Member Price

Showing 1 to 3 of 3 entries